Stay updated with breaking news from Access Pool. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
WHO's COVID-19 Technology Access Pool and the Medicines Patent Pool today finalized a licensing agreement with the Spanish National Research Council for a COVID-19 serological antibody technology.
According to the latest figures from Joint United Nations Programme on AIDS (UNAIDS), underinvestment in the Human Immuno-deficiency Virus (HIV) responses of low- and middle-income countries
UNAIDS welcomes the agreement between the Medicines Patent Pool (MPP) and the pharmaceutical company Merck Sharp & Dohme through which the intellectual property rights over an antiviral medicine to treat mild to moderate forms of COVID-19 in adult patients are shared with interested sub-licensees on a non-exclusive and transparent basis. The new medicine, molnupiravir, is
UNAIDS welcomes the agreement between the Medicines Patent Pool (MPP) and the pharmaceutical company Merck Sharp & Dohme through which the
NeelikaMalavige, a professor at Sri Lanka's Sri Jayewardenepura University has been appointed as a member of the World Health Organization's Technical Advisory Committee on Covid 19.